Prelude Capital Management’s Intermolecular, Inc. IMI Stock Holding History

Prelude Capital Management’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,000	Closed	-$47K	–	2267
2019 Q2	$47K	Sell	40,000 -110,024	-73%	-$126K	﹤0.01%	1130
2019 Q1	$173K	Sell	150,024 -34,693	-19%	-$37.9K	0.01%	764
2018 Q4	$187K	Buy	184,717 +156,786	+561%	+$157K	0.01%	749
2018 Q3	$33K	Buy	+27,931	New	+$40K	﹤0.01%	1223
2016 Q2	–	Sell	-8,490	Closed	-$21K	–	1833
2016 Q1	$21K	Buy	+8,490	New	+$19.1K	﹤0.01%	1112

Prelude Capital Management's IMI Position: Q3 2019 in Review

Prelude Capital Management sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 40,000 shares — an estimated $47K sold.

Prelude Capital Management first reported a position in IMI in Q1 2016 and held it in 5 quarters. The position peaked at $187K in Q4 2018. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.

Prelude Capital Management reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
Prelude Capital Management sold 40,000 Intermolecular, Inc. shares in Q3 2019, an estimated $47K.
Prelude Capital Management first reported a position in Intermolecular, Inc. in Q1 2016 and held it in 5 quarters.
Prelude Capital Management's Intermolecular, Inc. position peaked at $187K in Q4 2018.
0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.